Price movement over the last 24 hours
ARK Genomic Revolution ETF vs Global X Copper Miners ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Global X Copper Miners ETF trades at $75.9. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Global X Copper Miners ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | COPX | |
|---|---|---|
Sector | Sector/Thematic | Commodities - Metals/Agriculture |
52-Week High | $43.57 | $95.70 |
52-Week Low | $23.09 | $42.75 |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
COPX, the Global X Copper Miners ETF, trades at $76.54, up 1.51% today, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The ETF provides diversified exposure to copper mining companies, capitalizing on structural demand from AI data centers and electrification. Recent news highlights copper's critical role in the AI boom, though supply constraints and market fragility pose challenges. A dividend of $0.26 is scheduled for July 2026.
The long-term outlook for COPX is supported by strong copper demand drivers, but near-term technical weakness and speculative volatility present risks. Investment appeal hinges on the execution of the electrification theme and miners' ability to overcome supply bottlenecks. Analyst sentiment remains cautiously optimistic given copper's fundamental tailwinds.
Trailing returns across standard periods
Latest headlines on both assets
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →COPX tracks the Solactive Global Copper Miners Total Return Index, providing broad exposure to companies worldwide involved in copper mining, refining, and exploration. It serves as an equity-based alternative to copper futures, offering a leveraged play on copper demand driven by global infrastructure and the clean energy transition.
Read more on COPX →